Yamantürk P, Ozek M, Sevgi S, Eroglu L
Department of Pharmacology and Clinical Pharmacology, Istanbul Faculty of Medicine, Istanbul University, Capa, Turkey.
Ther Drug Monit. 2000 Oct;22(5):545-8. doi: 10.1097/00007691-200010000-00007.
Therapeutic drug monitoring (TDM) has assumed an important place in patient management in the last few decades. In this study, serum drug levels determined in 7759 specimens sent to the Department of Pharmacology and Clinical Pharmacology in 1994 and 1998 for TDM were retrospectively evaluated. Monitored drugs were carbamazepine, valproate, phenytoin, phenobarbital, digoxin, theophylline, and salicylate. The comparison of the results obtained for the relevant 2 years showed that there was a remarkable increase in the number of requests for TDM per year and in the rate of serum drug levels that were within therapeutic range. Serum antiepileptic drug level monitoring accounted for a major part of the data. Overall data suggest that the use of TDM in antiepileptic drugs is improving; conversely, digoxin and theophylline are still not being properly monitored. In this study, the results are discussed in the light of rational TDM criteria.
在过去几十年中,治疗药物监测(TDM)在患者管理中占据了重要地位。在本研究中,对1994年和1998年送往药理与临床药理系进行TDM的7759份标本所测定的血清药物水平进行了回顾性评估。监测的药物有卡马西平、丙戊酸盐、苯妥英、苯巴比妥、地高辛、茶碱和水杨酸盐。对这两年相关结果的比较表明,每年TDM的申请数量以及血清药物水平在治疗范围内的比例均有显著增加。血清抗癫痫药物水平监测占数据的主要部分。总体数据表明,抗癫痫药物TDM的使用正在改善;相反,地高辛和茶碱仍未得到妥善监测。在本研究中,根据合理的TDM标准对结果进行了讨论。